Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
